A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in miceEric M. Green, Christine E. Seidman, Robert L. Anderson et al.|Science|2016Cited by 710
SETD3 is an actin histidine methyltransferase that prevents primary dystociaAlex W. Wilkinson, Or Gozani, James A. Spudich et al.|Nature|2018Cited by 171
Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac MyosinArjun S. Adhikari, Kathleen M. Ruppel, Kristina B. Kooiker et al.|Cell Reports|2016Cited by 94
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activityArjun S. Adhikari, Kathleen M. Ruppel, Darshan V. Trivedi et al.|Nature Communications|2019Cited by 90
Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed stateAlison Schroer Vander Roest, Daniel Bernstein, Chao Liu et al.|Proceedings of the National Academy of Sciences|2021Cited by 81